A novel report on global Synthetic Blood Substitutes market is published by Emergen Research, offering current developments and emerging trends of the market. The report offers a comprehensive overview of the market along with details about market size, market share, revenue growth, and top companies. The report covers all crucial and essential information related to global Synthetic Blood Substitutes market to help readers, investors, clients to gain a thorough understanding of the market and invest accordingly. Various advanced statistical tools such as SWOT analysis or Porter’s Five Forces are used in the report.

In today's competitive marketplace, staying ahead of the curve is essential for businesses of all sizes. Understanding consumer behavior, market trends, and emerging opportunities is crucial for making informed decisions and developing effective strategies. Emergen Research recognizes this need and has invested significant resources in developing a cutting-edge market research content library. 

The newly launched Synthetic Blood Substitutes market research content is meticulously crafted by industry experts, leveraging extensive data analysis, and a deep understanding of various markets. This rich collection includes in-depth reports, whitepapers, case studies, trend analyses, and industry insights covering a wide range of sectors, including but not limited to technology, healthcare, finance, consumer goods, and manufacturing. 

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/146 

The synthetic blood substitute market is expected to grow from an estimated USD 9.6 billion in 2024 to USD 37.1 billion in 2033 at a CAGR of 16.20%

The primary driver of market expansion is expected to be the increasing usage of synthetic blood substitutes. Artificial blood is made from a variety of sources, including stem cells, recombinant haemoglobin, animal blood, human blood, and microbes. Since artificial blood is considered the universal blood group and may be given to patients of any blood type, it has a number of advantages over human blood. Additionally, artificial blood replacements don't trigger any immune responses.

Additionally, compared to human blood, which has a 42-day shelf life, artificial blood substitutes have a longer shelf life and can be stored for up to three years at room temperature, eliminating the possibility of contamination or infectious diseases during transfusion. Artificial blood is easily kept and can be utilized in emergency scenarios. For patients who refuse blood from donors because of their religious convictions, it is also a great choice. These are all the specific elements that drive the market's expansion.

The market is anticipated to grow due to the increasing need for blood transfusions. Globally, trauma and blood loss are leading causes of morbidity and death. The World Health Organisation (WHO) estimates that trauma claims the lives of over 1.3 million people annually, with blood loss being a major contributing cause.

According to recent research, just 2-3% of trauma victims obtain a blood transfusion, despite the fact that 25% of them need one. This highlights the need for blood, hence driving the demand for artificial blood substitutes. The need for artificial blood substitutes is being driven by the rising prevalence of trauma, especially in developing nations, which is brought on by violent crimes, natural catastrophes, and traffic accidents.

According to the WHO, reportedly, 1.19 million people die globally each year due to road accidents, making it a leading cause of death for young adults. Blood substitutes have the potential to lower fatality rates among trauma patients by offering rapid oxygen supply and fluid resuscitation.

Competitive Landscape: 

The latest study provides an insightful analysis of the broad competitive landscape of the global Synthetic Blood Substitutes market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. 

Rising Number of Surgical Procedures

Increasing rates of unintentional injuries, high rates of chronic illness, and ageing populations worldwide are all contributing factors to the rise in surgical procedures. Orthopaedic, neuro, dental, spinal cord, and ophthalmic (ear, nose, throat) surgeries are the most common surgeries globally. The most common procedure in the US is knee replacement surgery, according to data released by the American medical facility Personalised Orthopaedics of the Palm Beaches.

With a high success rate, around 800,000 knee replacement procedures are carried out annually in the US. Additionally, the American College of Rheumatology (ACR) reports that around 5,44,000 hip replacements and 7,90,000 complete knee replacements are carried done each year in the United States. Approximately 1 in 9 Americans have reported having at least one surgical procedure in the past, according to the National Institutes of Health (NIH).

Those over 65 accounted for the largest percentage of surgical patients. One of the most common surgical procedures in North America is joint replacement or prosthetic attachment. Over 2.8 million joint surgeries were performed in North America in 2022, according to the American Joint Replacement Registry (AJRR). Thus, the increasing number of surgical procedures is expected to drive the demand for synthetic blood substitutes, as 18% to 67% of patients undergoing surgery require a blood transfusion.

Emergen Research is Offering a full report (Grab a Copy Now) @ https://www.emergenresearch.com/industry-report/synthetic-blood-substitutes-market

Market Segmentation: 

The report bifurcates the Synthetic Blood Substitutes market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. 

Our goal at Emergen Research is to empower businesses with the knowledge and insights necessary to make informed decisions and thrive in today's dynamic business landscape. Our market research content is designed to equip professionals and organizations with comprehensive analyses, actionable recommendations, and a competitive edge to achieve their growth objectives. 

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/146 

The synthetic blood substitute market is expected to grow from an estimated USD 9.6 billion in 2024 to USD 37.1 billion in 2033 at a CAGR of 16.20%

The primary driver of market expansion is expected to be the increasing usage of synthetic blood substitutes. Artificial blood is made from a variety of sources, including stem cells, recombinant haemoglobin, animal blood, human blood, and microbes. Since artificial blood is considered the universal blood group and may be given to patients of any blood type, it has a number of advantages over human blood. Additionally, artificial blood replacements don't trigger any immune responses.

Additionally, compared to human blood, which has a 42-day shelf life, artificial blood substitutes have a longer shelf life and can be stored for up to three years at room temperature, eliminating the possibility of contamination or infectious diseases during transfusion. Artificial blood is easily kept and can be utilized in emergency scenarios. For patients who refuse blood from donors because of their religious convictions, it is also a great choice. These are all the specific elements that drive the market's expansion.

The market is anticipated to grow due to the increasing need for blood transfusions. Globally, trauma and blood loss are leading causes of morbidity and death. The World Health Organisation (WHO) estimates that trauma claims the lives of over 1.3 million people annually, with blood loss being a major contributing cause.

According to recent research, just 2-3% of trauma victims obtain a blood transfusion, despite the fact that 25% of them need one. This highlights the need for blood, hence driving the demand for artificial blood substitutes. The need for artificial blood substitutes is being driven by the rising prevalence of trauma, especially in developing nations, which is brought on by violent crimes, natural catastrophes, and traffic accidents.

According to the WHO, reportedly, 1.19 million people die globally each year due to road accidents, making it a leading cause of death for young adults. Blood substitutes have the potential to lower fatality rates among trauma patients by offering rapid oxygen supply and fluid resuscitation.

Target Audience of the Global Synthetic Blood Substitutes Market Report: 

• Key Market Players 

• Investors 

• Venture capitalists 

• Small- and medium-sized and large enterprises 

• Third-party knowledge providers 

• Value-Added Resellers (VARs) 

• Global market producers, distributors, traders, and suppliers 

• Research organizations, consulting companies, and various alliances interested in this sector 

• Government bodies, independent regulatory authorities, and policymakers 

Key Features of the Synthetic Blood Substitutes Market Report:

• The report offers details about key drivers, restraints, opportunities, challenges, growth prospects, limitations, and threats
• The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares
• Evaluation of key current and emerging market trends and growth prospects
• It also offers research-backed estimations for the forecast period of eight years, primarily to estimate the potential market growth
• Brief overview of industry with regards to research and development, technological advancements, and product development
• In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario

The synthetic blood substitute market is expected to grow from an estimated USD 9.6 billion in 2024 to USD 37.1 billion in 2033 at a CAGR of 16.20%

The primary driver of market expansion is expected to be the increasing usage of synthetic blood substitutes. Artificial blood is made from a variety of sources, including stem cells, recombinant haemoglobin, animal blood, human blood, and microbes. Since artificial blood is considered the universal blood group and may be given to patients of any blood type, it has a number of advantages over human blood. Additionally, artificial blood replacements don't trigger any immune responses.

Additionally, compared to human blood, which has a 42-day shelf life, artificial blood substitutes have a longer shelf life and can be stored for up to three years at room temperature, eliminating the possibility of contamination or infectious diseases during transfusion. Artificial blood is easily kept and can be utilized in emergency scenarios. For patients who refuse blood from donors because of their religious convictions, it is also a great choice. These are all the specific elements that drive the market's expansion.

The market is anticipated to grow due to the increasing need for blood transfusions. Globally, trauma and blood loss are leading causes of morbidity and death. The World Health Organisation (WHO) estimates that trauma claims the lives of over 1.3 million people annually, with blood loss being a major contributing cause.

According to recent research, just 2-3% of trauma victims obtain a blood transfusion, despite the fact that 25% of them need one. This highlights the need for blood, hence driving the demand for artificial blood substitutes. The need for artificial blood substitutes is being driven by the rising prevalence of trauma, especially in developing nations, which is brought on by violent crimes, natural catastrophes, and traffic accidents.

According to the WHO, reportedly, 1.19 million people die globally each year due to road accidents, making it a leading cause of death for young adults. Blood substitutes have the potential to lower fatality rates among trauma patients by offering rapid oxygen supply and fluid resuscitation.

About Emergen Research  

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. 

Contact Us: 

Eric Lee 

Corporate Sales Specialist 

Emergen Research | Web: https://www.emergenresearch.com/ 

Direct Line: +1 (604) 757-9756 

E-mail: sales@emergenresearch.com